News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
783,214 Results
Type
Article (71485)
Company Profile (772)
Press Release (710935)
Multimedia
Podcasts (150)
Webinars (24)
Section
Business (209461)
Career Advice (3315)
Deals (37603)
Drug Delivery (133)
Drug Development (85226)
Employer Resources (178)
FDA (17253)
Job Trends (16590)
News (360850)
Policy (35727)
Tag
Academia (2950)
Academic (2)
Accelerated approval (18)
Adcomms (30)
Allergies (127)
Alliances (51877)
ALS (145)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (242)
Approvals (17316)
Artificial intelligence (452)
Autoimmune disease (93)
Automation (29)
Bankruptcy (352)
Best Places to Work (12553)
BIOSECURE Act (23)
Biosimilars (162)
Biotechnology (459)
Bladder cancer (135)
Brain cancer (50)
Breast cancer (515)
Cancer (4026)
Cardiovascular disease (341)
Career advice (2819)
Career pathing (38)
CAR-T (250)
CDC (56)
Cell therapy (675)
Cervical cancer (33)
Clinical research (71088)
Collaboration (1409)
Company closure (4)
Compensation (947)
Complete response letters (56)
COVID-19 (2854)
CRISPR (82)
C-suite (611)
Cystic fibrosis (140)
Data (4779)
Decentralized trials (2)
Denatured (41)
Depression (107)
Diabetes (440)
Diagnostics (7039)
Digital health (35)
Diversity (12)
Diversity, equity & inclusion (42)
Drug discovery (211)
Drug pricing (188)
Drug shortages (33)
Duchenne muscular dystrophy (201)
Earnings (83832)
Editorial (53)
Employer branding (21)
Employer resources (154)
Events (125138)
Executive appointments (996)
FDA (19810)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1276)
Gene editing (173)
Generative AI (37)
Gene therapy (530)
GLP-1 (966)
Government (5191)
Grass and pollen (8)
Guidances (372)
Healthcare (20814)
HIV (47)
Huntington's disease (36)
IgA nephropathy (61)
Immunology and inflammation (230)
Immuno-oncology (20)
Indications (58)
Infectious disease (3098)
Inflammatory bowel disease (189)
Inflation Reduction Act (16)
Influenza (100)
Intellectual property (196)
Interviews (625)
IPO (17754)
IRA (59)
Job creations (4482)
Job search strategy (2336)
Kidney cancer (16)
Labor market (75)
Layoffs (625)
Leadership (35)
Legal (8432)
Liver cancer (89)
Longevity (11)
Lung cancer (573)
Lymphoma (267)
Machine learning (30)
Management (63)
Manufacturing (644)
MASH (143)
Medical device (14760)
Medtech (14785)
Mergers & acquisitions (20800)
Metabolic disorders (1116)
Multiple sclerosis (136)
NASH (21)
Neurodegenerative disease (213)
Neuropsychiatric disorders (59)
Neuroscience (2678)
NextGen: Class of 2025 (7529)
Non-profit (5076)
Now hiring (39)
Obesity (524)
Opinion (306)
Ovarian cancer (139)
Pain (171)
Pancreatic cancer (175)
Parkinson's disease (239)
Partnered (29)
Patents (422)
Patient recruitment (334)
Peanut (57)
People (64179)
Pharmaceutical (139)
Pharmacy benefit managers (28)
Phase I (22040)
Phase II (31003)
Phase III (23352)
Pipeline (2790)
Policy (287)
Postmarket research (3005)
Preclinical (9708)
Press Release (71)
Prostate cancer (201)
Psychedelics (49)
Radiopharmaceuticals (278)
Rare diseases (673)
Real estate (6960)
Recruiting (73)
Regulatory (25765)
Reports (46)
Research institute (2648)
Resumes & cover letters (517)
Rett syndrome (16)
RNA editing (14)
RSV (73)
Schizophrenia (138)
Series A (211)
Series B (158)
Service/supplier (29)
Sickle cell disease (80)
Special edition (24)
Spinal muscular atrophy (164)
Sponsored (40)
Startups (3879)
State (2)
Stomach cancer (14)
Supply chain (101)
Tariffs (90)
The Weekly (107)
Vaccines (997)
Venture capital (64)
Weight loss (353)
Women's health (51)
Worklife (21)
Date
Today (29)
Last 7 days (798)
Last 30 days (2722)
Last 365 days (32424)
2025 (27036)
2024 (37525)
2023 (42261)
2022 (53563)
2021 (58513)
2020 (57484)
2019 (51054)
2018 (38753)
2017 (35158)
2016 (34974)
2015 (40950)
2014 (34985)
2013 (32893)
2012 (32458)
2011 (32698)
2010 (31665)
Location
Africa (1063)
Alabama (79)
Alaska (7)
Arizona (257)
Arkansas (14)
Asia (45682)
Australia (8127)
California (9704)
Canada (2899)
China (929)
Colorado (406)
Connecticut (431)
Delaware (277)
Europe (106414)
Florida (1436)
Georgia (322)
Hawaii (3)
Idaho (66)
Illinois (797)
India (53)
Indiana (476)
Iowa (20)
Japan (332)
Kansas (124)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1301)
Massachusetts (7254)
Michigan (311)
Minnesota (577)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2700)
New Mexico (31)
New York (2632)
North Carolina (1424)
North Dakota (10)
Northern California (4457)
Ohio (306)
Oklahoma (22)
Oregon (51)
Pennsylvania (2020)
Puerto Rico (20)
Rhode Island (46)
South America (1407)
South Carolina (51)
South Dakota (1)
Southern California (3717)
Tennessee (152)
Texas (1516)
United States (35674)
Utah (293)
Virginia (252)
Washington D.C. (84)
Washington State (836)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
783,214 Results for "lyophilization services of new england".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
October 29, 2025
·
6 min read
Press Releases
Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine
October 17, 2025
·
7 min read
Press Releases
The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
October 20, 2025
·
8 min read
Press Releases
DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
October 13, 2025
·
13 min read
Press Releases
New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump
September 1, 2025
·
5 min read
Press Releases
MagicRNA’s First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.
September 18, 2025
·
5 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine
September 17, 2025
·
12 min read
Press Releases
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
September 1, 2025
·
13 min read
Press Releases
Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer
September 8, 2025
·
33 min read
Press Releases
New England Journal of Medicine (NEJM) to Publish Results From Savara’s Pivotal Phase 3 IMPALA-2 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
August 21, 2025
·
7 min read
1 of 78,322
Next
